J&J sews up 5 years of coronavirus vaccine supply in $480M-plus deal with Emergent
by Kyle Blankenship

Johnson & Johnson, like all drugmakers in the COVID-19 vaccine race, is hoping to cobble together enough manufacturing capacity to rapidly scale production of its shot hopeful. Now, to the tune of nearly half a billion dollars, J&J is ready to put its money where its mouth is.

J&J and Maryland-based CDMO Emergent BioSolutions inked a five-year work order worth at least $480 million to help produce the New Jersey-based drugmaker’s COVID-19 vaccine candidate, Emergent said in a release.

Click HERE to read Emergent’s press release. 

Read More

To tears from his parishioners, a man of the cloth and for the people of Camden is retiring — at 85
by Valerie Russ, Posted: July 5, 2020

Msgr. Michael J. Doyle (the Irish Chamber’s 2016 Uachtarán Award honoree) came to Sacred Heart Church in Camden in 1974 and saw a city ravaged by poverty and white flight.

Many of the church’s white parishioners had fled to Pennsauken, or Cherry Hill, or other South Jersey suburbs.

As a result, both the church and Sacred Heart School struggled to stay afloat. About 80% of the school’s current students are not Catholic.

But poverty did not scare Father Michael, as his congregation calls him. He was born in Ireland on a farm, the second of five children.

Read More

Last week, the PA Supreme Court granted allocator in the matter of Ryan Fell Mortimer v. 340 Associates, et al., Docket Nos.: 37 MAP 2020 and 38 MAP 2020.  The specific issue the Supreme Court is considering is whether Pennsylvania should adopt the “enterprise theory” or “single entity” theory of piercing the corporate veil when two or more sister companies operate as a single corporate combine.  More detailed information about this case is attached.

This case could adversely affect businesses and companies throughout Pennsylvania that operate through multiple entities, to include real estate owners/developers, healthcare providers, hotel owners, and retail stores.